FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s original application for a generic ipratropium bromide and albuterol sulfate inhalation product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (ipratropium bromide and albuterol sulfate)

Snippet

ORIG AP for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)